Xarelto is a prescription medication that was originally approved by the FDA in 2011 to prevent blood clots in patients that recently underwent knee or hip replacement surgery. Xarelto was designed to treat up to six different medical conditions that affect the way the body heals and prevents bleeding. Rivaroxaban, the active ingredient in Xarelto, can help reduce a patient’s risk of suffering from:
• Deep Vein Thrombosis
• Pulmonary Embolism
• Blood Clots
Xarelto is one member of a new family of anti-coagulant, or blood-thinner, drugs known as New Oral Anti-Coagulants (NOACs) which were marketed by promising increased convenience and freedom for patients. However, the tragic reality is that this medication has been linked to serious and even life-threatening side-effects, and thousands of patients are at risk.
Risks Associated with Xarelto
Johnson & Johnson subsidiary Janssen Pharmaceuticals and the Bayer Corporation first developed Xarelto as an alternative to older blood-thinners that required patients to take monthly blood tests. Xarelto treated the same types of medical conditions, but promised patients that they would no longer have to undergo this type of monthly monitoring. However, new information has concluded that there is no data to support Xarelto’s claim that patients would no longer require monthly blood tests. In fact, thousands of patients taking Xarelto have been seriously or even fatally harmed by this medication after dangerous side-effects were left unchecked by their doctors. Xarelto has been linked to several serious, or even fatal, side effects that have no known antidote or treatment options.
Potential side effects include:
• Gastrointestinal Bleeding
• Bleeding in the Brain
• Coughing or Vomiting Blood
• Uncontrollable Internal Bleeding
• Bloody stool
Warnings to Patients
In 2012, Xarelto received a Black Box warning from the Food and Drug Administration. These types of warning labels are reserved only for medications that pose a significant risk of serious or life-threatening side effects for patients. Despite the strong link between Xarelto and uncontrollable bleeding, the drug remained on the market and has placed thousands of patients at risk. The pharmaceutical companies responsible for manufacturing and marketing Xarleto are now facing numerous liability claims alleging that they did not properly warn the public of the associated risks of taking their medication. Hundreds of patients continue to come forward to seek damages, claiming that they were seriously harmed by the medication and were not made fully aware of the potential side-effects.
Protecting Your Rights as a Victim
At Graves McLain, Tulsa, Oklahoma Defective Medication law firm, we take pride in advocating for the rights of our patients and standing up to major drug manufacturers. In many cases, these companies put profits ahead of the safety and well-being of their customers. When pharmaceutical manufacturers fail to properly warn patients about the potential dangers of a medication, they must be held responsible for their actions.
If you or a loved one was seriously injured after taking the medication Xarelto, call the experienced Defective Medication lawyers at Graves McLain right away at (800) 390-6600. When you call, you will speak with an experienced, compassionate Defective Medication attorney absolutely FREE. We will review the details of your case and help you understand your rights as a victim.When you trust our firm to take your case, you will never pay an attorney’s fee unless we achieve a recovery for you. At Graves McLain, we take every case on a contingency fee basis, which means that we do not get paid until you do. Your case and your injuries are serious. At Graves McLain, we treat them that way.
If you have been harmed by a defective or dangerous drug, time may be running out to file a claim. Call Graves McLain today.
Graves McLain – Serious Lawyers for Serious Injuries.